Peptides, BPC-157, and the Mainlining of Pseudoscientific Nonsense 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic Critical Commentary takes a deep dive into one argument on a systemic problem in autoimmune drug development - trial design, regulatory strategy, industry incentives, or the gap between evidence and practice
I believe this is motivated by profit, and will be marketed by fear, when the time comes to distribute the new cure. I believe they will produce honest numbers, when the timing benefits the sale of a pharmaceutical treatment, which I would treat with skepticism
Biol Psychiatry 45 : 1725
View pre-care instructions Yes
They did also talk about One study assessed the mutagenicity and teratogenicity of the compound, basically looking at, do any mutations occur by injecting, or are there any effects of like fetal development? That one study did not prove that there was any kind of that ill effect occurring from BPC-157, but that doesnt mean its safe